Browse result page of THPdb

The total number entries retrieved from this search are 44

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
1005	Th1002	Cetuximab	Heavy chain:QVQLKQSG Full view	243	IIIc	Cancer	Erbitux	ImClone Systems Inc	Sterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates	Intravenous infusion	Antineoplastic Agents	Epidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
1025	Th1004	Denileukin diftitox	MGADDVVDSSKSFVMENFSS Full view	255	IIb	Cancer	Ontak	Seragen Inc	Sterile, white, preservative-free, lyophilized powder.	Intravenous(IV) administration	Antineoplastic Agents	Interleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma
1038	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Eligard	Atrix Labs/QLT In	Suspension	Subcutaneous Injection	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1039	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Enantone	Takeda	Solution	Injection	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1040	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Leuplin	Takeda	N.A.	Injection	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1041	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	LeuProMaxx	Baxter/Teva	N.A.	N.A.	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1042	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Leupromer	N.A.	N.A.	Injection	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1043	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Lupron	Abbott/TAP Pharmaceuticals	N.A.	Injection	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1044	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Lutrate	N.A.	N.A.	N.A.	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1045	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Memryte	Curaxis	N.A.	N.A.	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1046	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Prostap 3	Takeda UK Limited	N.A.	N.A.	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1047	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Prostap SR	Takeda UK Limited	N.A.	N.A.	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1048	Th1007	Leuprolide	PHWSYLLR Full view	8	IIa	Cancer	Viadur	Bayer AG	N.A.	N.A.	Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	Gonadotropin-releasing hormone receptor
1142	Th1020	Asparaginase	QMSLQQELRYIEALSAIVET Full view	255	Ic	Cancer	Elspar	Merck & Co. Inc	Lyophilized plug or powder	Intravenous or Intramuscular. Intravenous method dose has higher risk of allergic reaction, so often a test dose is given first.	Antineoplastic Agents	L-asparagine
1257	Th1036	Aldesleukin	MAPTSSSTKKTQLQLEHLLL Full view	134	Ib	Cancer/Infectious	Proleukin	Chiron Corp	Sterile, white to off-white, lyophilized cake	Intravenous administration	Antineoplastic Agents, Anti-HIV agents	Interleukin-2 receptor subunit beta,Interleukin-2 receptor subunit alpha,Cytokine receptor common subunit gamma
1337	Th1048	Pegaspargase	MEFFKKTALAALVMGFSGAA Full view	255	Ic	Cancer	Oncaspar	Enzon Inc	Solution	Intravenous or Intramuscular administration	Antineoplastic Agents	L-asparagine
1341	Th1049	Interferon beta-1a	MSYNLLGFLQRSSNFQCQKL Full view	166	Ib	Cancer/Infectious/Immunological	Avonex	Biogen Inc	Lyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.	Intramuscular Injection	Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1342	Th1049	Interferon beta-1a	MSYNLLGFLQRSSNFQCQKL Full view	166	Ib	Cancer/Infectious/Immunological	Betaferon	Bayer	Powder and solvent that are made upto make solution.	Subcutaneous Injection	Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1343	Th1049	Interferon beta-1a	MSYNLLGFLQRSSNFQCQKL Full view	166	Ib	Cancer/Infectious/Immunological	Betaseron	Merck	Sterile, white to off-white powder	Subcutaneous Injection	Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1344	Th1049	Interferon beta-1a	MSYNLLGFLQRSSNFQCQKL Full view	166	Ib	Cancer/Infectious/Immunological	Blastoferon	Sidus	N.A.	N.A.	Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1345	Th1049	Interferon beta-1a	MSYNLLGFLQRSSNFQCQKL Full view	166	Ib	Cancer/Infectious/Immunological	Extavia	Novartis	Sterile, white to off-white powder	Subcutaneous Injection	Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1346	Th1049	Interferon beta-1a	MSYNLLGFLQRSSNFQCQKL Full view	166	Ib	Cancer/Infectious/Immunological	Rebif	Merck	Sterile solution in a prefilled syringe or REBIF Rebidose autoinjector	Subcutaneous Injection	Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1385	Th1061	Trastuzumab	Light chain 1: DIQMT Full view	1364	IIa	Cancer	Herceptin	Genentech	Sterile, white to pale yellow, preservative-free lyophilized powder	 Intravenous administration	Antineoplastic Agents	Insulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
1389	Th1062	Rituximab	Heavy Chain: QVQLQQP Full view	664	IIa	Cancer/Immunological	Rituxan	Biogen Idec Inc., and Genentech USA, Inc	Sterile, clear, colorless, preservative-free liquid concentrate	 Intravenous administration	Antineoplastic Agents, Immunologic Factors and Antirheumatic Agents	B-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
1548	Th1117	Ipilimumab	Heavy chain: QVQLVES Full view	663	IIIc	Cancer	YERVOY	Bristol-Myers Squibb	Sterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	N.A.	Antineoplastic Agents and Monoclonal antibodies	Cytotoxic T-lymphocyte protein 4
1615	Th1133	Aflibercept	SDTGRPFVEMYSEIPEIIHM Full view	431	Ib	Cancer	Eylea	Regeneron Pharmaceuticals	Sterile, clear, and colorless to pale yellow solution.	Intravitreal injection	Antineoplastic Agents and Ophthalmics	Vascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
1616	Th1133	Aflibercept	SDTGRPFVEMYSEIPEIIHM Full view	431	Ib	Cancer	Zaltrap	Sanofi and Regeneron Pharmaceuticals, Inc.	Sterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.	Intravenous infusion	Antineoplastic Agents and Ophthalmics	Vascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
1636	Th1142	Obinutuzumab	N.A. Full view	0	IIb	Cancer	Gazyva	Genentech	Sterile, clear, colorless to slightly brown, preservative free liquid concentrate	Intravenous infusion	Antineoplastic Agents	B-lymphocyte antigen CD20
1671	Th1159	Gemtuzumab ozogamicin	Light Chain 1: QIVLT Full view	459	IIb	Cancer	Mylotarg	Wyeth pharmaceuticals inc	Sterile, white, preservative-free lyophilized powder	Intravenous infusion	Antineoplastic agents and Immunotoxins	Myeloid cell surface antigen CD33, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
1708	Th1170	Blinatumomab	DIQLTQSPASLAVSLGQRAT Full view	504	IIIc	Cancer/Genetic	Blincyto	AMGEN	Lyophilized Powder for intravenous administration	Intravenous	Antineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	B-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
1724	Th1174	Daratumumab	NA Full view	0	IIIc	Cancer	Darzalex	Janssen Biotech, Inc.	Solution, concentrate	Intravenous	Antineoplastic Agents	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
1797	Th1191	Vedolizumab	Heavy Chain Sequence Full view	716	IIa	Immunological Disorders	Entyvio	Takeda Pharmaceuticals America, Inc.	Injection, Powder, Lyophilized, for Solution	Intravenous	Immunosupressive agent, Antineoplastic agent	Integrin alpha-4, Integrin beta-7
1798	Th1192	Ustekinumab	NA Full view	0	IIIb	Infectious Disease	Stelara	Janssen Biotech, Inc.	Solution fro Injection	Subcutaneous	Deramtologic agent, Immunosuppressive agent, antineoplastic agent	Interleukin-12 subunit beta
1802	Th1196	Siltuximab	Heavy Chain Sequence Full view	708	IIa	Immunological Disorders	Sylvant	Janssen Inc	Lyophilized Powder	Intravenous infusion	Antineoplastic and Immunomodulating Agents, Immunosuppressive Agents	Interleukin-6
1805	Th1199	Ramucirumab	ramucirumab|Homo sap Full view	909	IIIc	Cancer	Cyramza	Eli Lilly and Company	Solution	Intravenous	Antineoplastic and Immunomodulating Agents	Vascular endothelial growth factor receptor 2
1811	Th1202	Pembrolizumab	Heavy Chain Sequence Full view	711	IIIc	Cancer	Keytruda	Merck Sharp & Dohme Corp.	Lyophilized Powder	Intravenous infusion	Antineoplastic and Immunomodulating Agents	Programmed cell death protein 1
1813	Th1204	Ofatumumab	Ofatumumab Heavy Cha Full view	483	IIIc	Cancer	Arzerra	Glaxo Smith Kline Llc	Liquid	Intravenous	Antineoplastic and Immunomodulating Agents
1815	Th1206	Nivolumab	Heavy Chain Sequence Full view	710	IIIc	Cancer	Opdivo	E.R. Squibb & Sons, L.L.C.	Liquid	Intravenous	Antineoplastic and Immunomodulating Agents	Programmed cell death protein 1
1819	Th1210	Mepolizumab	NA Full view	0	Ib	Respiratory Disorder	Nucala	Glaxosmithkline Inc	Lyophilized Powder	Subcutaneous	Antineoplastic and Immunomodulating Agents, Immunosuppressive Agents, Interleukin Inhibitors	Interleukin-5
1830	Th1220	Brodalumab	NA Full view	0	IIa	Immunological Disorders	Siliq	NA	sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution	Subcutaneous	Antineoplastic and Immunomodulating Agents	Interleukin 17 receptor A
1832	Th1222	Canakinumab	H-GAMMA-1 Chain: QVQ Full view	842	IIa	Immunological Disorders	Ilaris	Novartis	Lyphilized powder	Subcutaneous	Antineoplastic and Immunomodulating Agents	Interleukin-1 beta
1837	Th1226	Dinutuximab	NA Full view	0	IIIc	Cancer	unituxin	NA	sterile, preservative-free, clear/colorless to slightly opalescent solution	Intravenous	Antibody, Immunosuppresive agent, Antineoplastic agent	Ganglioside GD2 (small molecule)
1844	Th1232	Lenograstim	NA Full view	0	Ib	Immunological Disorders	Granocyte	NA	Solid	Subcutaneous or Intravenous	Antineoplastic and Immunomodulating Agents	Granulocyte colony-stimulating factor receptor
1848	Th1236	Sipuleucel-T	NA Full view	0	IIIc	Cancer	Provenge	NA	Solution	Intravenous	Antineoplastic and Immunomodulating Agents	Prostatic acid phosphatase